{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:38:05Z","timestamp":1790793485879,"version":"4.1.0"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2021,6,1]]},"DOI":"10.1001\/jamaneurol.2021.0688","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T15:30:44Z","timestamp":1616167844000},"page":"699","source":"Crossref","is-referenced-by-count":261,"title":["Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis"],"prefix":"10.1001","volume":"78","author":[{"given":"Amber","family":"Salter","sequence":"first","affiliation":[{"name":"Washington University School of Medicine in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Fox","sequence":"additional","affiliation":[{"name":"Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Newsome","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June","family":"Halper","sequence":"additional","affiliation":[{"name":"Consortium of MS Centers, Hackensack, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K. B.","family":"Li","sequence":"additional","affiliation":[{"name":"The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Kanellis","sequence":"additional","affiliation":[{"name":"MS Society of Canada, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Costello","sequence":"additional","affiliation":[{"name":"National Multiple Sclerosis Society, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Bebo","sequence":"additional","affiliation":[{"name":"National Multiple Sclerosis Society, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kottil","family":"Rammohan","sequence":"additional","affiliation":[{"name":"University of Miami School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Cutter","sequence":"additional","affiliation":[{"name":"The University of Alabama at Birmingham, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne H.","family":"Cross","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"noi210015r1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S1474-4422(20)30147-2","article-title":"An Italian programme for COVID-19 infection in multiple sclerosis.","volume":"19","author":"Sormani","year":"2020","journal-title":"Lancet Neurol"},{"issue":"10","key":"noi210015r2","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1177\/1352458520941485","article-title":"COVID-19 in people with multiple sclerosis: a global data sharing initiative.","volume":"26","author":"Peeters","year":"2020","journal-title":"Mult Scler"},{"issue":"10","key":"noi210015r3","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States: a population-based estimate using health claims data.","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology"},{"issue":"18","key":"noi210015r5","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China.","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"issue":"13","key":"noi210015r6","doi-asserted-by":"publisher","first-page":"382","DOI":"10.15585\/mmwr.mm6913e2","article-title":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019: United States, February 12-March 28, 2020.","volume":"69","author":"Chow","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"noi210015r8","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000835","article-title":"COVID-19 outcomes in MS: observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center.","volume":"7","author":"Parrotta","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"noi210015r9","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/jamaneurol.2020.2581","article-title":"Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis.","volume":"77","author":"Louapre","year":"2020","journal-title":"JAMA Neurol"},{"key":"noi210015r10","article-title":"Neurology and the COVID-19 pandemic: gathering data for an informed response.","author":"High","journal-title":"Neurol Clin Pract"},{"issue":"2","key":"noi210015r12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"9","key":"noi210015r14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.21892","article-title":"Racial disparities in incidence and outcomes among patients with COVID-19.","volume":"3","author":"Mu\u00f1oz-Price","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"noi210015r15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.12270","article-title":"Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit.","volume":"3","author":"Suleyman","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"26","key":"noi210015r16","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMsa2011686","article-title":"Hospitalization and mortality among Black patients and white patients with COVID-19.","volume":"382","author":"Price-Haywood","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"noi210015r17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value.","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"noi210015r18","article-title":"Disease-modifying therapies and coronavirus disease 2019 severity in multiple sclerosis.","author":"Sormani","journal-title":"Ann Neurol"},{"key":"noi210015r19","article-title":"Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.","author":"Strangfeld","journal-title":"Ann Rheum Dis"},{"issue":"6504","key":"noi210015r20","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"issue":"9","key":"noi210015r21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041437","article-title":"Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults.","volume":"10","author":"Ader","year":"2020","journal-title":"BMJ Open"},{"issue":"7","key":"noi210015r24","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.","volume":"79","author":"Gianfrancesco","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"noi210015r25","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time.","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"noi210015r26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.22310","article-title":"Risk factors for hospitalization, mechanical ventilation, or death among 10?131 US veterans with SARS-CoV-2 infection.","volume":"3","author":"Ioannou","year":"2020","journal-title":"JAMA Netw Open"},{"key":"noi210015r27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117147","article-title":"COVID-19 in multiple sclerosis patients and risk factors for severe infection.","volume":"418","author":"Chaudhry","year":"2020","journal-title":"J Neurol Sci"},{"issue":"6","key":"noi210015r28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China.","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"issue":"10223","key":"noi210015r29","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"noi210015r4","unstructured":"Multiple Sclerosis International Federation. Atlas of MS. Published September 2020. Accessed October 24, 2020. http:\/\/www.atlasofms.org"},{"key":"noi210015r7","unstructured":"Instituto Superiore di Sanit\u00e0. Characteristics of COVID-19 patients dying in Italy. Accessed October 9, 2020. https:\/\/www.epicentro.iss.it\/coronavirus\/bollettino\/Report-COVID-2019_20_marzo_eng.pdf"},{"key":"noi210015r11","unstructured":"MS Data Alliance. COVID-19 and MS: global data sharing initiative. Accessed October 9, 2020. https:\/\/msdataalliance.com\/covid-19\/covid-19-and-ms-global-data-sharing-initiative\/"},{"key":"noi210015r13","unstructured":"Michelen? M, Jones? N, Stavropoulou? C. In patients of COVID-19, what are the symptoms and clinical features of mild and moderate cases? The Centre for Evidence-Based Medicine. Published April 1, 2020. Accessed October 9, 2020. https:\/\/www.cebm.net\/covid-19\/in-patients-of-covid-19-what-are-the-symptoms-and-clinical-features-of-mild-and-moderate-case"},{"key":"noi210015r22","unstructured":"National Institutes of Health. NIH clinical trial testing remdesivir plus interferon beta-1a for COVID-19 treatment begins. Published August 6, 2020. Accessed October 9, 2020. https:\/\/www.nih.gov\/news-events\/news-releases\/nih-clinical-trial-testing-remdesivir-plus-interferon-beta-1a-covid-19-treatment-begins"},{"key":"noi210015r23","doi-asserted-by":"crossref","unstructured":"Sormani? MP, De Rossi? N, Schiavetti? I, ? Disease modifying therapies and COVID-19 severity in multiple sclerosis.? SSRN Electron J. Published online June 15, 2020. doi:10.2139\/ssrn.3631244.","DOI":"10.2139\/ssrn.3631244"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2777735\/jamaneurology_salter_2021_oi_210015_1622672586.64882.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T15:42:39Z","timestamp":1623339759000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2777735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2021.0688","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}